HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Venoms

Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling prey or predator.
Also Known As:
Venom
Networked: 3166 relevant articles (180 outcomes, 301 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Gutiérrez, José María: 42 articles (01/2016 - 03/2002)
2. Isbister, Geoffrey K: 36 articles (01/2016 - 12/2002)
3. Calvete, Juan J: 25 articles (06/2015 - 11/2007)
4. Hyslop, Stephen: 24 articles (01/2016 - 04/2003)
5. Brown, Simon G A: 23 articles (01/2016 - 03/2003)
6. Lomonte, Bruno: 19 articles (01/2015 - 08/2002)
7. Girish, K S: 18 articles (12/2015 - 01/2002)
8. Hodgson, Wayne C: 18 articles (11/2015 - 05/2003)
9. Rucavado, Alexandra: 18 articles (05/2015 - 10/2003)
10. Kemparaju, K: 17 articles (12/2015 - 01/2002)

Related Diseases

1. Hypersensitivity (Allergy)
2. Bites and Stings (Sting)
3. Anaphylaxis (Anaphylactic Shock)
4. Insect Bites and Stings (Insect Bite)
5. Asthma (Bronchial Asthma)
11/01/1988 - "A seventh patient developed asthma, 12 hours following a maintenance dose of 50 micrograms of yellow jacket venom. "
03/01/2012 - "For the American line: Clowes published the first successful trial of ragweed SCIT (1913); Cooke used skin prick testing as diagnostic method (1915); Loveless used venom immunotherapy with purified venom (not whole body extract) (1956); in 1961/1968 Johnstone showed in a DBPC-RCT dose-effect of an allergen mix and highly significant asthma reduction after up to 14 yrs of treatment of asthmatic children; Lowell and Franklin did the first DB-RCT demonstrating ragweed pollen efficacy as part of a multi-allergen mix and 1967 ragweed pollen extract dose response. "
01/01/2001 - "A total of 5,108 immunotherapy doses were administered to 339 patients (123 males and 216 females): 254 patients (75%) received mite, 48 patients (14.1%) pollen, 7 patients (2%) cat, 2 patients (0.6%) Alternaria alternata, and 38 patients (11.2%) hymenoptera venom immunotherapy; 238 patients (70.2%) had rhinoconjunctivitis and asthma, 59 (17.4%) rhinoconjunctivitis, 5 (1.4%) asthma, and 38 (11.2) hymenoptera sensitivity. "
04/01/2007 - "It is effective treatment for sensitivity to Hymenoptera venom and for allergic rhinitis and allergic asthma. "
01/01/1987 - "In allergic asthma and in Hymenoptera venom sensitivity patients, IgE-dependent activation of platelets expressed by the release of cytocidal mediators and oxidative burst can be specifically triggered by the corresponding allergen. "

Related Drugs and Biologics

1. Venoms
2. Immunoglobulin E (IgE)
3. Allergens
4. Epinephrine (Adrenaline)
5. Tryptases (Tryptase)
6. Antibodies
7. Immunoglobulin G (IgG)
8. Antivenins (Antivenoms)
9. Wasp Venoms (Venom, Wasp)
10. Peptides

Related Therapies and Procedures

1. Immunotherapy
2. Injections
3. Premedication
4. Subcutaneous Injections
5. Tourniquets